0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Cellular biology

Buy Now

Novel Methods and Pathways in Cancer Glycobiology Research, Volume 157 (Hardcover) Loot Price: R3,669
Discovery Miles 36 690
Novel Methods and Pathways in Cancer Glycobiology Research, Volume 157 (Hardcover): Charles J Dimitroff, Karen Abbott

Novel Methods and Pathways in Cancer Glycobiology Research, Volume 157 (Hardcover)

Charles J Dimitroff, Karen Abbott

Series: Advances in Cancer Research

 (sign in to rate)
Loot Price R3,669 Discovery Miles 36 690 | Repayment Terms: R344 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Cancer glycobiology is a blazing hot area of cancer research with aberrant post-translational glycosylations on lipids and proteins considered critical for cancer development and metastasis. The NIH/NCI Alliance of Glycobiologists for Cancer Research is a consortium of (10) tumor glycobiology laboratories funded to investigate how cancer-associated glycans (CAG) impact the development and metastasis of cancer. The hope of this momentous effort is to discover CAGs for use as novel biomarkers to detect early-stage cancer or its aggressive behavior or, alternatively, as novel molecular targets with the promise of a curative approach to cancer therapy. The mission of the 'Alliance' is to study structure and function of CAGs in cancer development and to provide clinically useful biomarkers for detecting cancer early or the potential of metastasis. This charge has stimulated extensive collaborations across US and International institutions to accelerate discovery of glycan-based biomarkers to the forefront of NCI's efforts to diagnose early-stage cancer and provide curative anti-cancer therapies. The main goals of these research efforts are: 1. To identify and study how cancer-associated glycans functionally impact cancer growth and metastasis 2. To identify cancer-associated glycans that can serve as biomarkers for the detection or progression of cancer 3. To develop cancer-associated glycans as novel therapeutic targets for the treatment and cure of cancer This volume consists of (9) chapters, one from each funded laboratory, that reviews new methods and mechanisms highlighting glycoconjugates and their roles as cancer biomarkers and/or anti-cancer therapeutic targets.

General

Imprint: Academic Press Inc
Country of origin: United Kingdom
Series: Advances in Cancer Research
Release date: February 2023
First published: 2023
Volume editors: Charles J Dimitroff • Karen Abbott
Dimensions: 229 x 152mm (L x W)
Format: Hardcover
Pages: 312
ISBN-13: 978-0-323-99177-3
Categories: Books > Science & Mathematics > Biology, life sciences > Cellular biology > General
Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Virology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General
LSN: 0-323-99177-7
Barcode: 9780323991773

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners